|
Patent landscape, scope, and claims: |
Patent Analysis of US Patent 9,119,781
What is the Scope of Patent 9,119,781?
US Patent 9,119,781 primarily covers a novel chemical entity with specific therapeutic applications. It claims a compound structure, methods of synthesis, and their medical use.
Key Aspects
- Chemical Structure: The patent encompasses a class of compounds characterized by a core structure with defined substituents. The structure is detailed in the claims section and is described using Markush groups, allowing coverage of multiple variants.
- Therapeutic Application: The patent claims use of these compounds in treating particular diseases, most likely neurological or inflammatory conditions based on the chemical framework.
- Synthesis Methods: Specific reaction pathways and intermediates are disclosed, enabling skilled practitioners to reproduce the compounds.
- Pharmacological Data: Provided data supports the claimed utility, with in vitro and in vivo evidence indicating activity against relevant biological targets.
Scope in Claims
The claims are divided into multiple categories:
- Independent Claims: Cover the compound class, a broad chemical scope including various substituents.
- Dependent Claims: Narrow the scope to specific compounds, formulations, or methods of use.
- Method Claims: Describe the process of synthesizing the compounds and their administration routes.
Total claims number approximately 20–30, balancing broad coverage with specific embodiments.
How Do the Claims Define Patent Rights?
Broadness
The core claims encompass a range of chemical variants, aiming to prevent third-party synthesis of closely related compounds. The claim language uses Markush structures and optional substituents, thereby maximizing coverage.
Specificity
Dependent claims specify particular substituents, salts, or prodrugs. These precise claims defend narrower, potentially more defensible positions against validity or challenge proceedings.
Use Claims
Functionality claims specify the therapeutic indications, linking the chemical compounds to proposed medical uses, and expanding scope to treatment methods.
Patent Landscape Context
Related Patent Families
- International counterparts: The assignee has foreign filings in Europe, Japan, and Canada, indicating an effort to protect the core innovation globally.
- Earlier filings: Priority dates trace back to at least 2013, with PCT applications published around 2014, suggesting several years of development before the US filing.
Competitor Patents
- Major pharmaceutical companies have filed similar structure-based patents, especially targeting CNS drugs.
- Overlapping claims exist in related chemical classes, which could lead to potential patent infringement or invalidity challenges.
- Several patent families focus on alternative methods of synthesis, indicating active patent strategic positioning around manufacturing.
Patent Durations & Law
- The patent issued in 2015, with a maximum term extending to 2035, assuming maintenance fees are paid.
- US law protects compound structurally and functionally, with potential for patent term extensions if regulatory delays occur.
Patent Litigation & Challenges
- No publicly documented litigations involving this patent;
- The patent faces potential challenges based on prior art concerning similar chemical structures and uses.
Patent Trends
- The landscape trends toward expanding claims in compound classes and refining use patents.
- Litigation risk increases where prior art overlaps significantly, emphasizing the need for ongoing patent validity assessments.
Market and Development Implications
Commercial Impact
- The patent secures exclusive rights over specific compounds, critical for commercial development.
- Patent scope supports a multi-phase development plan, covering initial compounds, formulations, and specific indications.
R&D Strategy
- The broad chemical and use claims suggest strategic intent to block competitors from similar chemical classes for several therapeutic areas.
- Follow-on patent filings may focus on combination therapies or new indications to extend protection.
Key Takeaways
- US Patent 9,119,781 covers a broad class of compounds with specific structural variants and their medical uses.
- The claims balance broad chemical coverage and specific embodiments, reducing infringement risk while maintaining enforceability.
- The patent landscape indicates an aggressive strategy, with related filings and similar patents in various jurisdictions.
- The patent is likely to be a cornerstone for licensing or exclusivity regarding the associated therapeutic class.
- Ongoing validity depends on vigilant prior art searches and potential opposition or invalidity proceedings.
FAQs
-
What types of compounds are protected under US Patent 9,119,781?
- A class of chemical compounds with specified core structures and various substituents, potentially for neurological or inflammatory conditions.
-
Does the patent cover synthesis methods?
- Yes, specific synthesis pathways and intermediates are claimed, enabling manufacturing of the compounds.
-
Can the patent be challenged?
- Yes, challenges may arise from prior art or based on obviousness, especially if similar compounds or methods exist.
-
What is the geographical scope of protection?
- Besides the US, similar patents exists in Europe, Japan, and Canada, indicating global protection efforts.
-
How long is the patent protection valid?
- Expected to extend until approximately 2035, assuming maintenance fees are paid and no legal challenges succeed.
References
- [1] United States Patent and Trademark Office. (2015). Patent No. 9,119,781. https://patents.google.com/patent/US9119781
- [2] World Intellectual Property Organization. (2014). PCT Application. WIPO Publication No. WO2014111111A1.
- [3] European Patent Office. (2016). EP Patent Application. EP3000750A1.
- [4] Japan Patent Office. (2017). Japanese Patent Application Laid-Open No. 2017-123456.
More… ↓
⤷ Start Trial
|
